title: Prophylactic fluconazole promotes reepithelialization in full-face carbon dioxide laser skin resurfacing.
abstract: OBJECTIVE
  Laser skin resurfacing is used to treat photodamaged skin, rhytids, and acne scarring. Many patients are placed on antibiotics and antivirals pre- and postoperatively. The purpose of this study was to determine whether prophylactic fluconazole increased the rate of reepithelialization in patients undergoing full-face CO(2) laser skin resurfacing.
  
  
  METHODS
  Ninety-one patients underwent full-face CO(2) laser skin resurfacing with the Coherent Ultrapulse 5000C. At least two passes of 300 mJ, density 5, were used except periocularly. Study group I consisted of 48 consecutive patients who received either cephalexin or ciprofloxacin for 7 days postoperatively. Study group II consisted of 43 patients who received 300 mg of fluconazole on postoperative days 3-8, in addition to ciprofloxacin. Both groups received acyclovir 400 mg t.i.d. pre- and postoperatively.
  
  
  RESULTS
  Time to complete reepithelialization was compared between the groups by t-test. Group II reepithelialized significantly faster than group I (7.65 +/- 1.20 days vs. 10.27 +/- 2.94 days; P < 0.0001). Ninety-five percent of patients receiving fluconazole (group II) healed completely by day 9 versus only 53% of patients in group I.
  
  
  CONCLUSIONS
  Fluconazole administered postoperatively between days 3 and 8 significantly promotes reepithelialization in patients undergoing full-face CO(2) laser skin resurfacing.
authors.affiliation: Beckman Laser Institute and Medical Clinic, Irvine, California 92612, USA. hconn@laser.bli.uci.edu
authors.forename: H
authors.initials: H
authors.lastname: Conn
authors.forename: V S
authors.initials: VS
authors.lastname: Nanda
mesh_terms: D019072:Antibiotic Prophylaxis; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000494:pharmacology; D000998:Antiviral Agents / Q000008:administration & dosage; D005260:Female; D015725:Fluconazole / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D008875:Middle Aged; D011182:Postoperative Care / Q000379:methods*; D015361:Rhytidoplasty / Q000009:adverse effects / Q000379:methods*; D015595:Skin Aging; D013530:Surgical Wound Infection / Q000517:prevention & control*; D013997:Time Factors; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects
chemical_list: D000935:Antifungal Agents; D000998:Antiviral Agents; D015725:Fluconazole